L Rydén

7.8k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

L Rydén is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L Rydén has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L Rydén's work include Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). L Rydén is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). L Rydén collaborates with scholars based in Sweden, United States and Germany. L Rydén's co-authors include Anders Waldenström, Åke Hjalmarson, Finn Waagstein, A Vedin, Claes Wilhelmsson, Stig Holmberg, Hans Wedel, Johan Herlitz, Karl Swedberg and Lars Wilhelmsen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

L Rydén

17 papers receiving 1.1k citations

Hit Papers

EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INF... 1981 2026 1996 2011 1981 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
    1981 781 citations Åke Hjalmarson, Johan Herlitz et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Rydén Sweden 10 1.0k 246 206 144 98 19 1.3k
J Kjekshus Spain 7 1.2k 1.1× 161 0.7× 195 0.9× 146 1.0× 81 0.8× 10 1.4k
L Ceremuźyński Poland 17 1.1k 1.1× 238 1.0× 229 1.1× 164 1.1× 155 1.6× 76 1.5k
Magnus Edner Sweden 21 1.3k 1.3× 143 0.6× 152 0.7× 237 1.6× 77 0.8× 48 1.6k
J Kuch Poland 9 1.1k 1.0× 201 0.8× 113 0.5× 138 1.0× 158 1.6× 24 1.3k
Cesare Greco Italy 19 776 0.8× 256 1.0× 400 1.9× 141 1.0× 91 0.9× 100 1.2k
Bertram Pitt United States 10 789 0.8× 175 0.7× 328 1.6× 242 1.7× 67 0.7× 24 1.1k
N Pauly United Kingdom 8 1.3k 1.3× 122 0.5× 148 0.7× 272 1.9× 69 0.7× 16 1.5k
Myron H. Luria Israel 21 1.0k 1.0× 225 0.9× 522 2.5× 130 0.9× 47 0.5× 44 1.4k
William E. Harston United States 8 1.7k 1.6× 110 0.4× 222 1.1× 118 0.8× 121 1.2× 11 1.9k
Gerald W. Neuberg United States 13 1.6k 1.6× 90 0.4× 168 0.8× 154 1.1× 178 1.8× 26 1.9k

Countries citing papers authored by L Rydén

Since Specialization
Citations

This map shows the geographic impact of L Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Rydén more than expected).

Fields of papers citing papers by L Rydén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Rydén. The network helps show where L Rydén may publish in the future.

Co-authorship network of co-authors of L Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of L Rydén. A scholar is included among the top collaborators of L Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Rydén. L Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Martinez, F. Eduardo, et al.. (2017). Fungal coronary embolus while on extracorporeal membrane oxygenation.. PubMed. 45(5). 634–635. 1 indexed citations
2.
Kotseva, Kornelia, et al.. (2014). Principal results of the EUROASPIRE IV survey of CVD prevention and diabetes: lifestyle, risk factor and therapeutic management in coronary patients from 24 European regions. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
3.
Settergren, Magnus, Felix Böhm, L Rydén, & John Pernow. (2008). Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. European Heart Journal. 29(14). 1753–1760. 72 indexed citations
4.
5.
Rydén, L. (2000). Managing cardiovascular risk in patients with diabetes. Heart. 84(suppl 1). i23–i25. 1 indexed citations
6.
Ståhle, Agneta, et al.. (2000). Improved Physical Fitness and Quality of Life Following Training of Elderly Patients after Acute Coronary Events. Journal of Cardiopulmonary Rehabilitation. 20(6). 393–394. 30 indexed citations
7.
8.
Cornelissen-Guillaume, Germaine G, F. Halberg, Patrick Delmore, et al.. (1998). Chronobiologic analysis of ambulatory heart rate and blood pressure data from an implanted hemodynamic analyzer. 71(4). 177–181. 1 indexed citations
9.
Linde, Cecilia, et al.. (1996). Dual chamber pacing in patients with hypertrophic obstructive cardiomyopathy with and without obstruction at rest. Journal of the American College of Cardiology. 27(2). 74–74. 3 indexed citations
10.
Malmberg, K. & L Rydén. (1996). Intense metabolic control decreases long-term mortality and morbidity in diabetics with myocardial infarction. Journal of the American College of Cardiology. 27(2). 82–82. 2 indexed citations
11.
Fishbein, Michael C., S Kobayashi, L Rydén, et al.. (1990). Overestimation of myocardial infarct size by histologic measurement in a model of occlusion followed by reperfusion.. PubMed. 114(12). 1218–22. 6 indexed citations
12.
Herlitz, Johan, Nils Edvardsson, Stephen Holmberg, et al.. (1984). Göteborg Metoprolol Trial: effects on arrhythmias.. PubMed. 53(13). 27D–31D. 20 indexed citations
13.
Feleke, Elehu, et al.. (1983). Complaints of Cold Extremities among Patients on Antihypertensive Treatment. Acta Medica Scandinavica. 213(5). 381–385. 23 indexed citations
14.
Rydén, L, Krister Arnman, Johan Herlitz, et al.. (1983). A Double-Blind Trial of Metoprolol in Acute Myocardial Infarction. New England Journal of Medicine. 308(11). 614–618. 217 indexed citations
15.
Hjalmarson, Åke, Johan Herlitz, I. Málek, et al.. (1981). EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 318(8251). 823–827. 781 indexed citations breakdown →
16.
Harper, Richart W., et al.. (1976). Proceedings: Effect of therapeutic doses of lignocaine hydrochloride on effective refractory period of right ventricle in humans.. PubMed. 38(5). 536–536. 1 indexed citations
17.
Rydén, L, et al.. (1975). The reliability of intermittent ECG sampling in arrhythmia detection.. Circulation. 52(4). 540–545. 17 indexed citations
18.
Rydén, L, Åke Hjalmarson, H S Wasir, & Lars Werkö. (1974). Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.. Heart. 36(8). 811–821. 11 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kjekshus Breakdown of academic impact, for papers by L Ceremuźyński Breakdown of academic impact, for papers by Magnus Edner Breakdown of academic impact, for papers by J Kuch Breakdown of academic impact, for papers by Cesare Greco Breakdown of academic impact, for papers by Bertram Pitt Breakdown of academic impact, for papers by N Pauly Breakdown of academic impact, for papers by Myron H. Luria Breakdown of academic impact, for papers by William E. Harston Breakdown of academic impact, for papers by Gerald W. Neuberg
Rankless by CCL
2026